[PRESSWIRE] WESTERHAM, England, January 16, 2017 -- A major investment in the leading source of drug discovery industry information - Drug Target Review - has led to a comprehensive relaunch.
Press Releases in Pharmaceuticals
[PRESSWIRE] INDIANAPOLIS, January 5, 2017 -- Eli Lilly and Company (NYSE: LLY) today announced a series of changes to its organization and leadership structure to better align them with the company's growth opportunities.
[PRESSWIRE] BENGALURU, October 19, 2016 -- Jubilant Biosys is proud to announce the addition of Agilent Technologies' RapidFire/MS screening technology to its Integrated Drug Discovery Platform.
[PRESSWIRE] LONG BEACH, Calif. - 10 October, 2016 -- SCAN Health Plan announced today its 2017 benefit plans, which include a new Preferred Pharmacy program offering lower copayments for prescription drugs. In many counties this gives plan members the option to pay $0 for many commonly used generic drugs.
[PRESSWIRE] CHARLOTTESVILLE, Va. - 26 September, 2016 -- Cavion LLC, a pharmaceutical company developing T-type calcium channel (Cav3) inhibitors for the treatment of oncologic and neurologic diseases, announced today that Ranjit Bindra, MD, PhD and Nataniel Lester-Coll, MD will present preliminary results from an ongoing Yale University Cancer Center and Cavion-sponsored Phase 1 clinical trial at the Annual Meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO) being held in Boston, Massachusetts, September 25-28.
[PRESSWIRE] Calgary, Alberta, Canada - September 20, 2016 -- Developed by AOR, RYR Ankascin -568-R™ is the Only Patented, Clinically Studied, Regulatory Compliant, and Commercially Available Red Yeast Rice Extract Free of Monacolin K.
[PRESSWIRE] HELSINKI - 05 August, 2016 -- Caverion Corporation Investor news August 5, 2016 at 10.00 a.m. EEST - Caverion (HEX:CAV1V) delivers a Large Project for Novo Nordisk’s new insulin production facility in Hillerød, Denmark.
[PRESSWIRE] SAINT PETERSBURG, Russia - 11 July, 2016 -- Biotechnological company BIOCAD has developed innovative medicine for treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other autoimmune diseases.
[PRESSWIRE] STOCKHOLM - 08 July, 2016 -- Regulatory News: The interest in and acceptance of SciBase’s method for early detection of malignant melanoma is increasing, which is demonstrated by the fact that the 100th clinic in Germany installed SciBase’s device Nevisense in June. Sales of electrodes; an effect of the adoption of Nevisense, are steadily increasing and rose by 208 percent in Germany during 2015.
[PRESSWIRE] DUBLIN - 06 July, 2016 -- Hibergene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has launched its HG Group B Streptococcus (GBS) Test.